Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Upadacitinib improved multiple immune-related conditions in one patient.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The tool accurately tracks eyebrow hair loss in chemotherapy patients.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Lablab purpureus peptides may effectively kill cancer cells with fewer side effects.